Xperi Inc. (XPER) — Insider Trading

AI-Powered SEC Filing Analysis

← All XPER filings

Want the newest filings?

This analysis covers the filing from 2026-04-21. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Insider Trading filings

Filed: 2026-04-21
  • Director Laura Durr acquired 29,320 restricted stock units (RSUs) on April 17, 2026, vesting within one year, indicating company confidence in near-term performance and director commitment to shareholder alignment.
  • The grant was issued at $0 price (standard for RSU grants), with Durr's total beneficial ownership reaching 111,561 shares directly plus 1,000 shares indirectly through the Durr Revocable Trust, demonstrating substantial personal investment in the company.
  • The RSU vesting structure tied to either April 17, 2027 or the next annual stockholders meeting creates incentive alignment and suggests the company expects to hold its annual meeting around that timeframe.
Filed: 2026-04-21
  • Director David C. Habiger received a grant of 29,320 restricted stock units (RSUs) on April 17, 2026, vesting within approximately one year, indicating continued equity compensation for board participation.
  • The grant carries no exercise price ($0) and represents standard director compensation rather than insider buying activity, suggesting routine board-level equity awards rather than conviction-based purchases.
  • Habiger's total beneficial ownership stands at approximately 135,315 shares (129,115 direct + 6,900 indirect through family trust), indicating modest but meaningful stake in the company.
Filed: 2026-04-21
  • Director Jeremi Gorman received a grant of 29,320 restricted stock units (RSUs) on April 17, 2026, vesting in approximately one year or at the next annual shareholder meeting, representing a standard equity compensation arrangement for board members.
  • The RSUs were granted at $0 exercise price, indicating this is a direct equity grant rather than an option, which is typical compensation structure for directors and suggests confidence in retention.
  • Following this transaction, Gorman's total beneficial ownership of XPER common stock increased to 78,018 shares, indicating a meaningful stake in the company as a director.
  • The filing shows no derivative securities activity and is signed by attorney-in-fact Robert J. Andersen, suggesting routine board-level compensation administration.
Filed: 2026-04-21
  • Director Darcy Antonellis received a grant of 29,320 restricted stock units (RSUs) on April 17, 2026, vesting within one year, indicating ongoing equity compensation for board-level service rather than open market acquisition.
  • The grant price of $0 reflects standard RSU compensation practice where directors receive equity awards as part of their compensation package, not a transaction at fair market value.
  • Post-transaction beneficial ownership stands at 125,606 shares, suggesting this director maintains a meaningful stake in the company aligned with shareholder interests.
  • The filing was signed by an attorney-in-fact (Robert J. Andersen) rather than the reporting person directly, which is common administrative practice for insiders but does not indicate any unusual circumstances.
Filed: 2026-04-21
  • Director Christopher A. Seams received a grant of 29,320 restricted stock units on April 17, 2026, with a $0 exercise price, indicating this is a compensatory equity award rather than a market purchase.
  • The RSUs vest in full on the earlier of April 17, 2027 or the next annual stockholders meeting, representing standard director compensation with a one-year vesting timeline.
  • Following this transaction, Seams maintains direct beneficial ownership of 130,269 shares of XPER common stock, demonstrating continued alignment with shareholder interests.
  • The filing was signed by Robert J. Andersen as attorney-in-fact, suggesting the director may have delegated Form 4 filing responsibilities to legal counsel.

Other reports for Xperi Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.